SAN DIEGO — No safety concerns were identified after intracameral injection of a steroid, NSAID and antibiotic combination in glaucoma patients undergoing cataract surgery with implantation of a supraciliary shunt, according to a speaker.
At the American Society of Cataract and Refractive Surgery meeting, David Stephens, MD, discussed a study conducted in 48 eyes of 31 patients who underwent cataract surgery and placement of the Alcon CyPass shunt. Each patient received an intracameral injection of DMK (dexamethasone, moxifloxacin and ketorolac, Imprimis) at the end of the procedure.
At 3
Uncategorized